User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series

Primary tabs

Peterson, Kevin [Institute of Tropical Medicine, Antwerp, Belgium] Ruelle, Jean [UCL] Vekemans, Marc [Institute of Tropical Medicine, Antwerp, Belgium] Siegal, Frederick P [Mount Sinai Medical Center, New York, NY, USA] Deayton, Jane R [Queen Mary University of London, London, UK] Colebunders, Robert [Institute of Tropical Medicine and Unviversity of Antwerp, Antwerp, Belgium]

We describe five patients with HIV-2 infection (four antiretroviral-experienced and one antiretroviral-naive) treated with a regimen containing raltegravir. All responded to treatment as demonstrated by viral load and CD4+ T-cell count monitoring. Our series confirms the clinical effectiveness of raltegravir in HIV-2-infected patients when given with other antiretrovirals to which the virus is susceptible.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2012
Language Anglais
Journal information "Antiviral Therapy" - Vol. 17, p. 1097-1100 (2012)
Peer reviewed yes
Publisher International Medical Press ((United Kingdom) London)
issn 1359-6535
Publication status Publié
Affiliations UCL - SSS/IREC/MBLG - Pôle de Microbiologie médicale
UCL - (SLuc) Service de microbiologie
Links
Bibliographic reference Peterson, Kevin ; Ruelle, Jean ; Vekemans, Marc ; Siegal, Frederick P ; Deayton, Jane R ; et. al. The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series. In: Antiviral Therapy, Vol. 17, p. 1097-1100 (2012)
Permanent URL http://hdl.handle.net/2078.1/114467